NCT01502202 Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers Status UNKNOWN Phase PHASE2
NCT01500018 Study in Healthy Recreational Polydrug Users to Measure the Abuse Potential of TC-5214 Status WITHDRAWN Phase PHASE1
NCT01499303 Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer Status COMPLETED Phase PHASE2
NCT01498185 BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes Status COMPLETED Phase PHASE2
NCT01498081 A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients Status COMPLETED Phase PHASE2
NCT01494402 Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01493544 Prevalence Study and Regular Practice Among General Practitioners in Populations at Risk of Chronic Obstructive Pulmonary Disease (COPD) in Latin America Status COMPLETED Phase N/A
NCT01491412 Non-interventional Study: Real-life Use of Atypical Antipsychotics in Acute Inpatient Management of Schizophrenia Status COMPLETED Phase N/A
NCT01491139 Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck Status WITHDRAWN Phase PHASE1
NCT01490645 A NIS Registry of the Prospective Structured Care In Acute Coronary Syndrome Status COMPLETED Phase N/A
NCT01490398 Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve Status COMPLETED Phase PHASE4
NCT01489722 Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients Status TERMINATED Phase PHASE1
NCT01486433 The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects Status COMPLETED Phase PHASE1
NCT01483950 Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values Status COMPLETED Phase N/A
NCT01482884 Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT01482221 A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder Status COMPLETED Phase PHASE2